BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2114 related articles for article (PubMed ID: 36138390)

  • 1. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Insurance Information Systems in China: Mixed Methods Study.
    Li Y; Lu C; Liu Y
    JMIR Med Inform; 2020 Sep; 8(9):e18780. PubMed ID: 32673209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience and reflection from China's Xiangya medical big data project.
    Li B; Li J; Jiang Y; Lan X
    J Biomed Inform; 2019 May; 93():103149. PubMed ID: 30878618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Big Data Technology for COVID-19 Prevention and Control in China: Lessons and Recommendations.
    Wu J; Wang J; Nicholas S; Maitland E; Fan Q
    J Med Internet Res; 2020 Oct; 22(10):e21980. PubMed ID: 33001836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Persistence and Change in China's Healthcare Insurance Reform: Clues from Fiscal Subsidy Policies Made for Settling COVID-19 Patients' Medical Costs.
    Ma T; Guo B; Xu J
    Risk Manag Healthc Policy; 2022; 15():1129-1144. PubMed ID: 35637742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievements and Challenges of the Healthcare System in China.
    Chen C; Liu M
    Cureus; 2023 May; 15(5):e39030. PubMed ID: 37378106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. China's Insurance Regulatory Reform, Corporate Governance Behavior and Insurers' Governance Effectiveness.
    Li H; Zhang H; Tsai SB; Qiu A
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29039781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health financing and integration of urban and rural residents' basic medical insurance systems in China.
    Zhu K; Zhang L; Yuan S; Zhang X; Zhang Z
    Int J Equity Health; 2017 Nov; 16(1):194. PubMed ID: 29115955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who pays for health care in China? The case of Heilongjiang province.
    Chen M; Zhao Y; Si L
    PLoS One; 2014; 9(10):e108867. PubMed ID: 25271768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sharing Economy in China's Aging Industry: Applications, Challenges, and Recommendations.
    Hu Y; Wang J; Nicholas S; Maitland E
    J Med Internet Res; 2021 Jul; 23(7):e27758. PubMed ID: 34255691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the Development of the Insurance Industry Promote the Purchase of Rural Commercial Health Insurance?
    Li C; Wang SF; Liu XH; Wang L
    Front Public Health; 2021; 9():695121. PubMed ID: 34368061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of insurance in the achievement of universal coverage within a developing country context: South Africa as a case study.
    van den Heever AM
    BMC Public Health; 2012; 12 Suppl 1(Suppl 1):S5. PubMed ID: 22992410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engaging sub-national governments in addressing health equities: challenges and opportunities in China's health system reform.
    Brixi H; Mu Y; Targa B; Hipgrave D
    Health Policy Plan; 2013 Dec; 28(8):809-24. PubMed ID: 23221008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New evidence on financing equity in China's health care reform--a case study on Gansu province, China.
    Chen M; Chen W; Zhao Y
    BMC Health Serv Res; 2012 Dec; 12():466. PubMed ID: 23244513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has equity in government subsidy on healthcare improved in China? Evidence from the China's National Health Services Survey.
    Si L; Chen M; Palmer AJ
    Int J Equity Health; 2017 Jan; 16(1):6. PubMed ID: 28069001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Development of Chinese Digital Resources under Lightweight Deep Learning.
    Song B
    Comput Intell Neurosci; 2022; 2022():3759129. PubMed ID: 35814587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 106.